- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Centene Corp (CNC)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: CNC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $43.06
1 Year Target Price $43.06
| 7 | Strong Buy |
| 3 | Buy |
| 9 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -5.4% | Avg. Invested days 35 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 22.91B USD | Price to earnings Ratio - | 1Y Target Price 43.06 |
Price to earnings Ratio - | 1Y Target Price 43.06 | ||
Volume (30-day avg) 19 | Beta 0.48 | 52 Weeks Range 25.08 - 66.81 | Updated Date 01/9/2026 |
52 Weeks Range 25.08 - 66.81 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -10.67 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.16% | Operating Margin (TTM) 0.55% |
Management Effectiveness
Return on Assets (TTM) 2.01% | Return on Equity (TTM) -21.86% |
Valuation
Trailing PE - | Forward PE 15.65 | Enterprise Value 21408024560 | Price to Sales(TTM) 0.14 |
Enterprise Value 21408024560 | Price to Sales(TTM) 0.14 | ||
Enterprise Value to Revenue 0.12 | Enterprise Value to EBITDA 3.91 | Shares Outstanding 491518000 | Shares Floating 489114477 |
Shares Outstanding 491518000 | Shares Floating 489114477 | ||
Percent Insiders 0.45 | Percent Institutions 96.67 |
Upturn AI SWOT
Centene Corp

Company Overview
History and Background
Centene Corporation was founded in 1984 by Michael F. Neidorff in Madison, Wisconsin, initially as a healthcare provider for low-income families. The company has since evolved significantly, focusing on government-sponsored healthcare programs. Key milestones include its initial public offering in 1997, numerous strategic acquisitions to expand its reach and capabilities, and its substantial growth fueled by the Affordable Care Act (ACA). Centene has become a leading managed care organization serving Medicaid, Medicare, and Health Insurance Marketplace plans.
Core Business Areas
- Managed Care: Centene provides a comprehensive range of managed care services through its health plans. This includes managing benefits for Medicaid, Medicare, and Health Insurance Marketplace members, often serving vulnerable populations and those with chronic conditions. Services encompass medical, behavioral, and pharmacy benefits management.
- Specialty Services: This segment includes specialized healthcare services such as behavioral health, care management, and pharmacy benefits management (PBM). These services are often integrated within their managed care offerings or provided as standalone solutions.
- Technology and Data Analytics: Centene invests in technology and data analytics to improve care quality, manage costs, and enhance member experience. This includes developing platforms for population health management and predictive analytics.
Leadership and Structure
Centene is led by a seasoned executive team. The organizational structure is largely segmented by product lines and geographic regions, with a focus on managing its diverse portfolio of government-sponsored health plans. Key leadership roles include the Chief Executive Officer, Chief Financial Officer, and heads of various operational and strategic divisions.
Top Products and Market Share
Key Offerings
- Medicaid Managed Care: Centene is a major provider of Medicaid managed care plans, offering comprehensive health coverage to low-income individuals and families. This is their largest and most significant business segment, serving millions of members across numerous states. Competitors include UnitedHealth Group (through UnitedHealthcare Community Plan), Elevance Health (through various Anthem BCBS plans), and CVS Health (through Aetna Medicaid).
- Health Insurance Marketplace Plans: Centene offers plans on the Health Insurance Marketplace (ACA exchanges), providing subsidized health insurance to individuals and families who do not have employer-sponsored coverage. Competitors include UnitedHealth Group, Elevance Health, and Kaiser Permanente (in specific markets).
- Medicare Advantage Plans: The company also provides Medicare Advantage (Part C) plans, which are private insurance alternatives to traditional Medicare. This segment is growing for Centene. Competitors include UnitedHealth Group, Humana, and CVS Health (through Aetna).
- Pharmacy Benefit Management (PBM) - Magellan Rx: Through its subsidiary Magellan Rx, Centene offers PBM services, including prescription drug benefit management, specialty pharmacy, and drug formulary management. Competitors include Express Scripts (Cigna), Optum Rx (UnitedHealth Group), and Caremark (CVS Health).
Market Dynamics
Industry Overview
The managed care industry in the US is heavily influenced by government policies and regulations, particularly regarding Medicaid, Medicare, and the ACA. The industry is characterized by intense competition, a focus on cost containment, and an increasing demand for integrated care solutions, including behavioral health and pharmacy benefits. Consolidation has been a significant trend, with larger players seeking scale and broader service offerings.
Positioning
Centene is a leading national provider of government-subsidized healthcare programs, with a particular strength in Medicaid managed care. Its competitive advantages lie in its deep experience serving vulnerable populations, its extensive geographic footprint, and its integrated approach to care management. The company has a proven track record of growth through acquisitions and organic expansion.
Total Addressable Market (TAM)
The total addressable market for government-sponsored healthcare programs in the US is vast and continues to grow, driven by an aging population, expanding eligibility for Medicaid, and ongoing healthcare reform efforts. Centene is well-positioned to capture a significant portion of this TAM, particularly within the Medicaid and Health Insurance Marketplace segments, due to its scale and specialized focus.
Upturn SWOT Analysis
Strengths
- Strong market position in government-sponsored healthcare programs (Medicaid, Medicare, Marketplace).
- Extensive geographic reach across 50 states.
- Proven track record of successful acquisitions and integration.
- Focus on serving vulnerable populations and managing complex care needs.
- Integrated care model encompassing medical, behavioral, and pharmacy benefits.
Weaknesses
- Reliance on government reimbursement rates and regulatory changes.
- Integration challenges with large-scale acquisitions.
- Potential for operational inefficiencies due to rapid growth.
- Competition from larger, more diversified healthcare companies.
Opportunities
- Expansion into new state Medicaid contracts.
- Growth in Medicare Advantage and dual-eligible populations.
- Increased demand for integrated behavioral health services.
- Leveraging technology and data analytics for improved care and cost management.
- Partnerships with providers and community organizations.
Threats
- Changes in healthcare policy and regulation (e.g., ACA repeal/replace, Medicaid block grants).
- Increased competition and pricing pressure.
- Rising healthcare costs and medical trend inflation.
- Cybersecurity risks and data breaches.
- Economic downturns impacting government budgets.
Competitors and Market Share
Key Competitors
- UnitedHealth Group (UNH)
- Elevance Health (ELV)
- CVS Health (CVS)
- Humana (HUM)
Competitive Landscape
Centene competes in a highly fragmented but consolidating market. Its primary advantages are its deep specialization in government-sponsored programs and its scale in serving vulnerable populations. However, it faces strong competition from larger, more diversified companies like UnitedHealth Group and Elevance Health, which have broader market penetration and more extensive integrated offerings. Centene's ability to execute on integrations and manage costs effectively are key to its competitive standing.
Major Acquisitions
WellCare Health Plans
- Year: 2020
- Acquisition Price (USD millions): 17300
- Strategic Rationale: The acquisition of WellCare significantly expanded Centene's scale and market presence, particularly in Medicaid and Medicare Advantage, solidifying its position as a leading government-focused managed care organization.
Magellan Health
- Year: 2022
- Acquisition Price (USD millions): 18500
- Strategic Rationale: This acquisition bolstered Centene's behavioral health capabilities and strengthened its position in the pharmacy benefit management (PBM) sector through Magellan Rx, enabling a more comprehensive and integrated approach to healthcare services.
Growth Trajectory and Initiatives
Historical Growth: Centene has experienced robust historical growth, largely fueled by strategic acquisitions that have expanded its membership base and geographic footprint. The company has consistently grown its revenue by acquiring other health plans, particularly those focused on government-sponsored programs.
Future Projections: Analyst projections for Centene's future growth typically focus on continued expansion within its core Medicaid and Medicare segments, as well as potential gains from new contract wins and the ongoing integration of acquired businesses. Growth is also expected from its specialty services and PBM segment.
Recent Initiatives: Recent initiatives have included efforts to streamline operations, enhance technological capabilities for better care management and data analytics, and focus on improving quality outcomes and member satisfaction within its health plans. The company has also been actively managing its portfolio, divesting non-core assets and strengthening its core government business.
Summary
Centene Corp is a dominant player in the US government-sponsored healthcare market, particularly Medicaid, with a proven growth strategy driven by acquisitions. Its strengths lie in serving vulnerable populations and its extensive geographic reach. However, it faces significant threats from regulatory changes and intense competition from larger, diversified players. The company needs to focus on operational efficiencies and leveraging its integrated care model to maintain its competitive edge and navigate the complex healthcare landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Centene Corporation Annual Reports (10-K)
- Centene Corporation Quarterly Reports (10-Q)
- Company Investor Relations Website
- Reputable Financial News Outlets (e.g., Bloomberg, Wall Street Journal)
- Industry Analysis Reports
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. This analysis is based on publicly available data and may not reflect all nuances of the company's operations or market conditions. Investing in the stock market involves inherent risks, and investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Market share percentages are estimates and can fluctuate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Centene Corp
Exchange NYSE | Headquaters Saint Louis, MO, United States | ||
IPO Launch date 2001-12-13 | CEO & Director Ms. Sarah M. London | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 60500 | Website https://www.centene.com |
Full time employees 60500 | Website https://www.centene.com | ||
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

